Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor
The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Abstract
A 3.5 angstrom resolution electron density map of the HIV-1 reverse transcriptase heterodimer complexed with nevirapine, a drug with potential for treatment of AIDS, reveals an asymmetric dimer. The polymerase (pol) domain of the 66-kilodalton subunit has a large cleft analogous to that of the Klenow fragment of Escherichia coli DNA polymerase I. However, the 51-kilodalton subunit of identical sequence has no such cleft because the four subdomains of the pol domain occupy completely different relative positions. Two of the four pol subdomains appear to be structurally related to subdomains of the Klenow fragment, including one containing the catalytic site. The subdomain that appears likely to bind the template strand at the pol active site has a different structure in the two polymerases. Duplex A-form RNA-DNA hybrid can be model-built into the cleft that runs between the ribonuclease H and pol active sites. Nevirapine is almost completely buried in a pocket near but not overlapping with the pol active site. Residues whose mutation results in drug resistance have been approximately located.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the connection domain lacks any catalytic site and has α–helices on only one side of the β–sheet (Figure 2a), compared to the RNH and IN domains (Figure 2b and 2c, respectively) [14].”
From Retroviral RNase H: structure, mechanism, and inhibition (2021) · cites this paper as [14]
In the citing paper
“The mature, functional form of HIV-1 RT is a heterodimer, comprising 66 kDa and 51 kDa subunits (Figure 1b)”
From Retroviral RNase H: structure, mechanism, and inhibition (2021) · cites this paper as [14]
In the citing paper
“the connection domain directly interacts with nucleic acids via positively charged side chains to help heterodimer formation and possibly position the substrate in the RNH active site [14,15].”
From Retroviral RNase H: structure, mechanism, and inhibition (2021) · cites this paper as [14]
Citations
Cites
Identification of four conserved motifs among the RNA-dependent polymerase encoding elements.
Poch, O., Sauvaget, I., Delarue, M., & Tordo, N. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb08565.x · Cited by 1,202
Multiple Mutations in HIV-1 Reverse Transcriptase Confer High-Level Resistance to Zidovudine (AZT)
Larder, B. A., & Kemp, S. D. (1989) · Science · doi:10.1126/science.2479983 · Cited by 1,163
Beese, L. S., & Steitz, T. A. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb07917.x · Cited by 1,048
Self-citationResolution of phase ambiguity in macromolecular crystallography
Wang, B.-C. (1985) · Methods in Enzymology · doi:10.1016/0076-6879(85)15009-3 · Cited by 1,028
The accuracy of reverse transcriptase from HIV-1
Roberts, J. D., Bebenek, K., & Kunkel, T. A. (1988) · Science · doi:10.1126/science.2460925 · Cited by 997
Fidelity of HIV-1 reverse transcriptase
Preston, B. D., Poiesz, B. J., & Loeb, L. A. (1988) · Science · doi:10.1126/science.2460924 · Cited by 931
Structure of large fragment of Escherichia coli DNA polymerase I complexed with dTMP
Ollis, D. L., Brick, P., Hamlin, R., Xuong, N. G., & Steitz, T. A. (1985) · Nature · doi:10.1038/313762a0 · Cited by 848
Self-citationWeiss, R. A., & Bernstein, A. (1982) · Cold Spring Harbor Laboratory eBooks · Cited by 828
Carson, M. (1991) · Journal of Applied Crystallography · doi:10.1107/s0021889891007240 · Cited by 808
Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives
Pauwels, R., Andries, K., Desmyter, J., Schols, D., Kukla, M. J., Breslin, H. J., Raeymaeckers, A., Gelder, J. V., Woestenborghs, R., Heykants, J., et al. (1990) · Nature · doi:10.1038/343470a0 · Cited by 756
Research works printed but not linked: 2
- Kohlstaedt, L. A., Proceedings of the National Academy of Sciences of the United States of America 89: 9652 (1992).
- VARMUS, H, REVERSE TRANSCRIPTION, SCIENTIFIC AMERICAN 257: 56 (1987).
Cited by
Items 801–900 of 1,005
Active Site Mapping of the Catalytic Mouse Primase Subunit by Alanine Scanning Mutagenesis
Copeland, W. C., & Tan, X. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.8.3905 · Cited by 37
Crystal structures of ribonuclease HI active site mutants from Escherichia coli.
Katayanagi, K., Ishikawa, M., Okumura, M., Ariyoshi, M., Kanaya, S., Kawano, Y., Suzuki, M., Tanaka, I., & Morikawa, K. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)80652-8 · Cited by 37
Closing in on HIV drug resistance.
Larder, B. A., & STAMMERS, D. K. (1999) · Nature Structural Biology · doi:10.1038/5787 · Cited by 43
Oisen, D. B., Carroll, S. S., Culberson, J. C., Shafer, J. A., & Kuo, L. C. (1994) · Nucleic Acids Research · doi:10.1093/nar/22.8.1437 · Cited by 36
Human Immunodeficiency Virus Type 1 Reverse Transcriptase
Jaju, M., Beard, W. A., & Wilson, S. H. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.17.9740 · Cited by 37
Novel Antibiotics Targeting Bacterial Replicative DNA Polymerases
Santos, J. A., & Lamers, M. H. (2020) · Antibiotics · doi:10.3390/antibiotics9110776 · Cited by 39
“Several non-nucleoside analogs used in antiviral therapies inhibit the HIV reverse transcriptase through binding of a non-catalytic pocket 10 Å away from the polymerase active site [51,52].”
BackgroundHa, B., Larsen, K. P., Zhang, J., Fu, Z., Montabana, E., Jackson, L. N., Chen, D.-H., & Puglisi, E. V. (2021) · Nature Communications · doi:10.1038/s41467-021-22628-9 · Cited by 35
Bao, K., & Cohen, S. N. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404386101 · Cited by 36
Efavirenz Binding to HIV-1 Reverse Transcriptase Monomers and Dimers
Braz, V. A., Holladay, L. A., & Barkley, M. D. (2009) · Biochemistry · doi:10.1021/bi901579y · Cited by 40
“hydrophobic pocket ~10 Å away from the polymerase active site in the p66 subunit of RT (8, 9).”
BackgroundMenéndez‐Arias, L., Abraha, A., Quiñones‐Mateu, M. E., Más, A., Camarasa, M., & Arts, E. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104342200 · Cited by 39
Ribonuclease H evolution in retrotransposable elements
Malik, H. S. (2005) · Cytogenetic and Genome Research · doi:10.1159/000084971 · Cited by 42
“involved in the heterodimerization of the p66 and p51 subunit in the active heterodimer (note that the p51 subunit lacks the RNH domain, but retains the tether) and in modulating RNH activity (Kohlstaedt et al., 1992).”
InfluentialBuckheit, R. W., Hartman, T. L., Watson, K. M., Kwon, H. S., Lee, S. H., Lee, J. W., Kang, D. W., Chung, S. G., & Cho, E. H. (2007) · Antiviral chemistry & chemotherapy · doi:10.1177/095632020701800502 · Cited by 36
“…characterized by binding to a deep hydrophobic pocket near the polymerase active site in the p66 palm subdomain of the enzyme (Condra et al., 1992; Kohlstaedt et al., 1992; Smerdon et al., 1994), having relatively no activity against HIV-2 (De Clercq, 1993; Buckheit et al., 1995), and resulting…”
BackgroundElder, J. H., & Phillips, T. R. (1995) · Advances in virus research · doi:10.1016/s0065-3527(08)60062-7 · Cited by 35
Perach, M., & Hizi, A. (1999) · Virology · doi:10.1006/viro.1999.9761 · Cited by 39
The Isolated RNase H Domain of Murine Leukemia Virus Reverse Transcriptase
Zhan, X., & Crouch, R. J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.35.22023 · Cited by 36
Subtype-associated differences in HIV-1 reverse transcription affect the viral replication
Iordanskiy, S., Waltke, M., Feng, Y., & Wood, C. A. (2010) · Retrovirology · doi:10.1186/1742-4690-7-85 · Cited by 42
“We analyzed the replication of two clones NL-RTpd (YU2) and NL-RTpd(1084), which contain sequences encoding the RT polymerase domain only from subtype B isolate YU-2 or subtype C isolate 1084 in the NL4-3 backbone (Figure 2D) (RT domains are indicated according to [35-37]).”
MethodWillis, S. H., Kazmierczak, K. M., Carter, R. H., & Rothman‐Denes, L. B. (2002) · Journal of Bacteriology · doi:10.1128/jb.184.18.4952-4961.2002 · Cited by 36
“This structure resembles a cupped hand in which thumb and fingers subdomains rise on each side of a palm subdomain (31).”
BackgroundBonner, G., Lafer, E. M., & Sousa, R. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31507-7 · Cited by 43
Kinetics of interaction of HIV reverse transcriptase with primer/template
Divita, G., Müller, B., Immendoerfer, U., Gautel, M., Rittinger, K., Restle, T., & Goody, R. S. (1993) · Biochemistry · doi:10.1021/bi00082a018 · Cited by 36
Xu, Z., Pilch, D. S., Srinivasan, A. R., Olson, W. K., Geacintov, N. E., & Breslauer, K. J. (1997) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(97)00050-3 · Cited by 36
Beard, W. A., Bębenek, K., Darden, T. A., Li, L., Prasad, R., Kunkel, T. A., & Wilson, S. H. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.46.30435 · Cited by 42
Essink, B. B. O., Das, A. T., & Berkhout, B. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.40.23867 · Cited by 41
Reverse transcriptase in motion: Conformational dynamics of enzyme–substrate interactions
Götte, M., Rausch, J. W., Marchand, B., Sarafianos, S. G., & Grice, S. F. J. L. (2009) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2009.07.020 · Cited by 44
Loya, S., Rudi, A., Kashman, Y., & Hizi, A. (2002) · Biochemical Journal · doi:10.1042/0264-6021:3620685 · Cited by 35
Elgaher, W. A. M., Sharma, K. K., Haupenthal, J., Saladini, F., Pires, M., Réal, É., Mély, Y., & Hartmann, R. W. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00730 · Cited by 39
Quan, Y., BRENNER, B. G., Marlink, R., Essex, M., Kurimura, T., & Wainberg, M. A. (2003) · AIDS Research and Human Retroviruses · doi:10.1089/088922203769232548 · Cited by 37
“31,32 Most of these changes are at the end or beginning of an a helix, for example, K43E, D123S/G, and Q174K/R.”
Paris, K. A., Haq, O., Felts, A. K., Das, K., Arnold, E., & Levy, R. M. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900854h · Cited by 41
Geitmann, M., Unge, T., & Danielson, U. H. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0504048 · Cited by 37
Binding of nucleic acids to E.coli RNase HI observed by NMR and CD spectroscopy
Oda, Y., Iwa, S., Ohtsuka, E., Ishikawa, M., Ikehara, M., & Nakamura, H. (1993) · Nucleic Acids Research · doi:10.1093/nar/21.20.4690 · Cited by 35
Sevilya, Z., Loya, S., Adir, N., & Hizi, A. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg235 · Cited by 40
Drug Resistance in Non-B Subtype HIV-1: Impact of HIV-1 Reverse Transcriptase Inhibitors
Singh, K., Flores, J., Kirby, K. A., Neogi, U., Sönnerborg, A. B., Hachiya, A., Das, K., Arnold, E., McArthur, C. P., Parniak, M. A., et al. (2014) · Viruses · doi:10.3390/v6093535 · Cited by 38
Sharaf, N. G., Ishima, R., & Gronenborn, A. M. (2016) · Biochemistry · doi:10.1021/acs.biochem.6b00113 · Cited by 37
Structure and function relationships in mammalian DNA polymerases
Hoitsma, N. M., Whitaker, A. M., Schaich, M. A., Smith, M. R., Fairlamb, M. S., & Freudenthal, B. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03368-y · Cited by 41
Rohman, M. S., Koga, Y., Takano, K., Chon, H., Crouch, R. J., & Kanaya, S. (2008) · The FEBS Journal · doi:10.1111/j.1742-4658.2008.06622.x · Cited by 35
Mechanistic aspects of HIV‐1 reverse transcription initiation
Harrich, D., & Hooker, C. W. (2002) · Reviews in Medical Virology · doi:10.1002/rmv.339 · Cited by 77
“The non-nucleoside inhibitor nevirapine (NVP) is a specific non-competitive inhibitor of RT that acts by a very different mechanism from nucleoside analogues [63].”
BackgroundAmacker, M., & Hübscher, U. (1998) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.1739 · Cited by 35
Menéndez‐Arias, L., Matamoros, T., & Cases‐González, C. E. (2006) · Current Pharmaceutical Design · doi:10.2174/138161206776873608 · Cited by 41
Antiretroviral Drug Resistance: Mechanisms, Pathogenesis, Clinical Significance
Richman, D. D. (1996) · Advances in experimental medicine and biology · doi:10.1007/978-1-4757-9209-6_35 · Cited by 38
Post, K., Guo, J., Kalman, E., Uchida, T., Crouch, R. J., & Levin, J. G. (1993) · Biochemistry · doi:10.1021/bi00072a004 · Cited by 34
Recent progress in the research of small molecule HIV-1 RNase H inhibitors
Cao, L., Song, W., Clercq, E., Zhan, P., & Liu, X. (2014) · Current Medicinal Chemistry · doi:10.2174/0929867321666140120121158 · Cited by 34
“The first 440 residues of p66 and p51 are identical, and in both subunits, these residues comprise four subdomains, termed “finger”, “palm”, “thumb” and “connection” [3].”
BackgroundTy3 reverse transcriptase complexed with an RNA-DNA hybrid shows structural and functional asymmetry
Nowak, E., Miller, J. T., Bona, M. K., Studnicka, J., Szczepanowski, R. H., Jurkowski, J., Le Grice, S. F. J., & Nowotny, M. (2014) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2785 · Cited by 31
“We document here important differences between Ty3 and HIV-1 RT. Firstly, for the LTR-retrotransposon enzyme, substrate binding is a pre-requisite to dimerization, while the lentiviral enzyme is a stable dimer in its absence 24,37,38 .”
Leung, C. S., Zeevaart, J. G., Domaoal, R. A., Bollini, M., Thakur, V. V., Spasov, K. A., Anderson, K. S., & Jorgensen, W. L. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.03.006 · Cited by 34
Multimodal Functionalities of HIV-1 Integrase
Engelman, A., & Kvaratskhelia, M. (2022) · Viruses · doi:10.3390/v14050926 · Cited by 41
“All three Pol protein domains, PR [237], RT [238], and IN [72,73,76,80], function as obligate enzyme multimers, and the IN domain, possibly in con-”
BackgroundRausch, J. W., Grice, M. K. B.-L., Henrietta, M., Nymark, M., Miller, J. T., & Grice, S. F. J. L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.18.13879 · Cited by 35
Viral gene products and replication of the human immunodeficiency type 1 virus
Morrow, C. D., Park, J., & Wakefield, J. (1994) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1994.266.5.c1135 · Cited by 49
Klunder, J. M., Hoermann, M., Cywin, C. L., David, E., Brickwood, J. R., Schwartz, R., Barringer, K., Pauletti, D., Shih, C.-K., Erickson, D. A., et al. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm9707028 · Cited by 34
Latham, G. J., & Lloyd, R. S. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)61933-2 · Cited by 36
Kim, B. S., & Loeb, L. A. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.3.684 · Cited by 38
Gupta, S., Vingerhoets, J., Fransen, S., Tambuyzer, L., Azijn, H., Frantzell, A., Paredes, R., Coakley, E. P. G., Nijs, S., Clotet, B., et al. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01695-10 · Cited by 37
“The C-terminal region of RT includes the connection domain (amino acids 319 to 426) and the RNase H domain (amino acids 427 to 560) (18, 22).”
BackgroundMarko, R., Liu, H.-W., Ablenas, C. J., Ehteshami, M., Götte, M., & Cosa, G. (2013) · The Journal of Physical Chemistry B · doi:10.1021/jp308674g · Cited by 35
Viral Drug Resistance and Fitness
Quiñones‐Mateu, M. E., Moore‐Dudley, D. M., Jegede, O., Weber, J., & Arts, E. J. (2008) · Advances in pharmacology · doi:10.1016/s1054-3589(07)56009-6 · Cited by 33
Rezende, L. F., & Prasad, V. R. (2004) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.02.025 · Cited by 40
Svenda, M., Berg, M., Moreno-Lopez, J., & Linné, T. (1997) · Virus Research · doi:10.1016/s0168-1702(96)01426-8 · Cited by 33
Shahriar, R., Rhee, S., Liu, T. F., Fessel, W. J., Scarsella, A., Towner, W. J., Holmes, S., Zolopa, A. R., & Shafer, R. W. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00592-09 · Cited by 33
Zhou, Z., Liu, T., Kang, D., Huo, Z., Wu, G., Daelemans, D., Clercq, E. D., Pannecouque, C. C., Zhan, P., & Liu, X. (2017) · Organic & Biomolecular Chemistry · doi:10.1039/c7ob02828h · Cited by 36
Das, D., & Georgiadis, M. M. (2001) · Protein Science · doi:10.1110/ps.16301 · Cited by 33
“The enzyme includes fingers, palm, thumb, connection, and RNase H structural domains as first described in the structure of the human immunodeficiency virus type-1 (HIV-1) RT complexed with nevirapine (Kohlstaedt et al. 1992).”
MethodSchultz, S. J., Zhang, M., Kelleher, C. D., & Champoux, J. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000021200 · Cited by 33
Subunit-Specific Analysis of the Human Immunodeficiency Virus Type 1 Reverse Transcriptase In Vivo
Mulky, A., Sarafianos, S. G., Arnold, E., Wu, X., & Kappes, J. C. (2004) · Journal of Virology · doi:10.1128/jvi.78.13.7089-7096.2004 · Cited by 39
“Therefore, the effects of a mutation in the RT coding region on subunit structure and function are not equivalent (2, 26).”
BackgroundInfluentialLi, Q., & Nargang, F. E. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.9.4299 · Cited by 33
Amacker, M., Hottiger, M. O., & Hübscher, U. (1995) · Journal of Virology · doi:10.1128/jvi.69.10.6273-6279.1995 · Cited by 33
Reverse transcriptase and substrate dependence of the RNA hypermutagenesis reaction
Martínez, M. Á., Sala, M., Vartanian, J., & Wain–Hobson, S. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.14.2573 · Cited by 34
Gel Shift and UV Cross-linking Analysis of Tetrahymena Telomerase
Harrington, L. A., Hull, C. M., Crittenden, J. R., & Greider, C. W. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.15.8893 · Cited by 33
Predicting the Zn(II) Ligands in Metalloproteins: Case Study, Porphobilinogen Synthase
Jaffe, E. K. (1993) · Comments on Inorganic Chemistry · doi:10.1080/02603599308035837 · Cited by 33
Lacey, S. F., & Larder, B. A. (1994) · Journal of Virology · doi:10.1128/jvi.68.5.3421-3424.1994 · Cited by 40
“It appears, however, that the amino acids implicated in AZT resistance interact with the RNA template and that altered interactions between the enzyme and the template might be responsible for the differential incorporation of AZT monophosphate into the elongating DNA strand (1, 3, 6).”
BackgroundBinding interface and impact on protease cleavage for an RNA aptamer to HIV-1 reverse transcriptase
Nguyen, P. D. M., Zheng, J., Gremminger, T., Qiu, L., Zhang, D., Tuske, S., Lange, M. J., Griffin, P. R., Arnold, E., Chen, S., et al. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkz1224 · Cited by 32
Lee, D., Oh, S.-H., Cho, H., Yoo, J., & Lee, G. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac043 · Cited by 32
Hepatitis C Virus RNA-Dependent RNA Polymerase (NS5B Polymerase)
Hagedorn, C. H., van Beers, E. H., & Staercke, C. D. (2000) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-59605-6_11 · Cited by 39
Dhillon, J., Cowley, J. A., Wang, Y., & Walker, P. J. (2000) · Virus Research · doi:10.1016/s0168-1702(00)00215-x · Cited by 32
Misincorporation by HIV-1 Reverse Transcriptase Promotes Recombination via Strand Transfer Synthesis
Palaniappan, C., Wisniewski, M., Wu, W., Fay, P. J., & Bambara, R. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.37.22331 · Cited by 34
“The initial endonucleolytic cleavage position is at a distance slightly smaller than the approximate 20-nucleotide spatial separation of DNA polymerase and RNase H active sites, as determined by x-ray crystallographic studies (Jacobo-Molina et al., 1993; Kohlstaedt et al., 1992).”
BackgroundSchultz, S. J., Zhang, M., Kelleher, C. D., & Champoux, J. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.49.34547 · Cited by 32
Kim, E., Vrang, L., Öberg, B. F., & Merigan, T. C. (2001) · AIDS Research and Human Retroviruses · doi:10.1089/088922201750102445 · Cited by 33
Interface Peptides as Structure-based Human Immunodeficiency Virus Reverse Transcriptase Inhibitors
Divita, G., Baillon, J. G., Rittinger, K., Chermann, J., & Goody, R. S. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.48.28642 · Cited by 36
Cywin, C. L., Klunder, J. M., Hoermann, M., Brickwood, J. R., David, E., Grob, P. M., Schwartz, R., Pauletti, D., Barringer, K., Shih, C.-K., et al. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm9707030 · Cited by 32
Lavrik, O. I., Prasad, R., Beard, W. A., Safronov, I. V., Dobrikov, M. I., Srivastava, D., Shishkin, G. V., Wood, T. G., & Wilson, S. H. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.36.21891 · Cited by 33
Latham, G. J., Forgacs, E., Beard, W. A., Prasad, R., Bębenek, K., Kunkel, T. A., Wilson, S. H., & Lloyd, R. S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000279200 · Cited by 33
Control of Initiation of Viral Plus Strand DNA Synthesis by HIV Reverse Transcriptase
Palaniappan, C., Kim, J. K., Wisniewski, M., Fay, P. J., & Bambara, R. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.7.3808 · Cited by 34
Kobayashi, S. (2000) · Hepatology Research · doi:10.1016/s1386-6346(99)00061-3 · Cited by 32
Cento, V., Mirabelli, C., Dimonte, S., Salpini, R., Han, Y., Trimoulet, P., Bertoli, A., Micheli, V., Gubertini, G., Cappiello, G., et al. (2012) · Journal of General Virology · doi:10.1099/vir.0.046524-0 · Cited by 31
Antiviral Drug Targets of Single-Stranded RNA Viruses Causing Chronic Human Diseases
Dinesh, D. C., Tamilarasan, S., Rajaram, K., & Bouřa, E. (2019) · Current Drug Targets · doi:10.2174/1389450119666190920153247 · Cited by 30
Matamoros, T., Kim, B., & Menéndez‐Arias, L. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.11.021 · Cited by 31
“The HIV-1 RT is a heterodimeric enzyme composed of two subunits of 66 and 51 kDa respectively, with subdomains termed fingers, thumb, palm and connection in both subunits and an RNase H domain in the larger subunit only.(2,3) The DNA polymerase active site resides within the palm subdomain of the larger subunit (p66),…”
BackgroundGriko, Y. V., Sreerama, N., Osumi-Davis, P. A., Woody, R. W., & Woody, A. M. (2001) · Protein Science · doi:10.1110/ps.39701 · Cited by 31
“1985) and HIV-1 reverse transcriptase (Kohlstaedt et al. 1992).”
BackgroundInfluentialChen, R., Yokoyama, M., Sato, H., Reilly, C., & Mansky, L. M. (2005) · Journal of Virology · doi:10.1128/jvi.79.18.12045-12057.2005 · Cited by 34
“The NRTI docking model with the information of the NNRTI binding site (18, 43) and the two basic models described above help explain the changes in mutation frequencies observed in the present study and in previous studies (25).”
BackgroundResultSahu, V., Khan, A., Singh, R. K., & Singh, P. P. (2008) · American Journal of Immunology · doi:10.3844/ajisp.2008.33.42 · Cited by 38
“This specificity of NNRTIs for the HIV-1-RT is due to presence in HIV-1RT and not in other RTs or DNA polymerases, of a flexible highly hydrophobic pocket in which a nonsubstrate analogue can fit snugly([2-4]).”
BackgroundDevelopment of peptide inhibitors of HIV transmission
Shi, S., Nguyen, P. K., Cabral, H., Diez-Barroso, R., Derry, P. J., Kanahara, S. M., & Kumar, V. (2016) · Bioactive Materials · doi:10.1016/j.bioactmat.2016.09.004 · Cited by 33
Structure, function, and evolution of bacterial reverse transcriptase
Inouye, S., & Inouye, M. (1995) · Virus Genes · doi:10.1007/bf01728650 · Cited by 33
Mulky, A., Sarafianos, S. G., Jia, Y., Arnold, E., & Kappes, J. C. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.03.057 · Cited by 31
Pelemans, H., Esnouf, R. M., Jonckheere, H., Clercq, E. D., & Balzarini, J. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.51.34234 · Cited by 31
Odriozola, L., Cruchaga, C., Andréola, M., Dollé, V., Nguyen, C. H., Tarrago‐Litvak, L., Pérez‐Mediavilla, A., & Martínez-Irujo, J. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212673200 · Cited by 31
Jeruzalmi, D., & Steitz, T. A. (1997) · Journal of Molecular Biology · doi:10.1006/jmbi.1997.1366 · Cited by 34
Self-citationXu, G., Micklatcher, M. L., Silvestri, M. A., Hartman, T. L., Burrier, J., Osterling, M. C., Wargo, H., Turpin, J. A., Robert W. Buckheit, & Cushman, M. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm010212m · Cited by 31
Challenges in the therapy of HIV infection
Yarchoan, R., Mitsuya, H., & Broder, S. E. (1993) · Immunology Today · doi:10.1016/0167-5699(93)90050-u · Cited by 32
Mutational Studies of Human DNA Polymerase α
Dong, Q., & Wang, T. S. ‐. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.37.21563 · Cited by 32
Fu, H., Guthrie, J. W., & Le, X. C. (2005) · Electrophoresis · doi:10.1002/elps.200500460 · Cited by 35
Wöhrl, B. M., Howard, K. J., Jacques, P. S., & Grice, S. F. L. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37229-0 · Cited by 32
Pisani, F. M., & Rossi, M. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37134-x · Cited by 31
Lai, M., Feng, M., Xu, M., Ngo, W., Diamond, T. L., Hwang, C. K., Grobler, J. A., Hazuda, D. J., & Asante‐Appiah, E. (2022) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02223-21 · Cited by 30
Kirby, K. A., Marchand, B., Ong, Y. T., Ndongwe, T. P., Hachiya, A., Michailidis, E., Leslie, M. D., Sietsema, D. V., Fetterly, T. L., Dorst, C. A., et al. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.06000-11 · Cited by 35
“exists as a heterodimer composed of two subunits: an enzymatically active 66-kDa p66 domain, which contains the polymerase domain (composed of the fingers, palm, thumb, and connection subdomains) and the RNase H domain, and a 51-kDa p51 domain, which mainly provides structural support and has an amino acid sequence id…”
BackgroundCazenave, C., Frank, P. H., Toulmé, J., & Büsen, W. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31515-6 · Cited by 30
Ekkati, A. R., Bollini, M., Domaoal, R. A., Spasov, K. A., Anderson, K. S., & Jorgensen, W. L. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.12.132 · Cited by 30
Agopian, A., Gros, E., Aldrian, G., Dereuddre‐Bosquet, N., Clayette, P., & Divita, G. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802199200 · Cited by 33
Metadata
- Authors
- Kohlstaedt, L. A., Wang, J., Friedman, J. M., Rice, P. A., & Steitz, T. A.
- Affiliations
- Howard Hughes Medical Institute (US)
- Venue
- Science
- Published
- 1992-06-26
- Volume
- 256
- Issue
- 5065
- Pages
- 1783-1790
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2008954911
- Cited by
- 1,914
- References
- 67
- Citations by year
- 2026: 11 · 2025: 16 · 2024: 13 · 2023: 16 · 2022: 22 · 2021: 29 · 2020: 18 · 2019: 24 · 2018: 37 · 2017: 39 · 2016: 39 · 2015: 38 · 2014: 44 · 2013: 63 · 2012: 42
- FWCI
- 128.45
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5p01gm039546-10)
- National Institute of General Medical Sciences (GM 39546)
- Topics
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Structural Biology › Enzyme Structure and Function
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Keywords
- HIV-1 reverse transcriptase, nevirapine, drug resistance, polymerase domain, asymmetric dimer, RNase H, RNA-DNA hybrids, active site, protein-inhibitor complex
- MeSH terms
- Azepines, Binding Sites, Crystallography, DNA Polymerase I, Escherichia coli, Models, Molecular, Protein Conformation, Pyridines, RNA-Directed DNA Polymerase, Molecular Structure, HIV-1, Nevirapine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.